Acute eosinophilic pneumonia in the elderly: A case report and literature review

doi:10.3969/j.issn.1004-583X.2022.10.009

Abstract

Abstract:

Objective To investigate the clinical characteristics, diagnosis and treatment of acute eosinophilic pneumonia. Methods The bronchoalveolar lavage and lung biopsy were performed in this patient, and glucocorticoid was managed, the pulmonary iconography result was recorded. Results The therapeutic result showed that the symptoms improved significantly, the pulmonary inflammatory exudates were completely absorbed. Conclusion This findings demonstrates that clinical symptoms of acute eosinophilic pneumonia are atypical, the glucocorticoid therapy following bronchoalveolar lavage and lung biopsy is quick and effective, with favourable prognosis.

Key words: pulmonary eosinophilia increased, pneumonia, bronchoalveolar lavage, glucocorticoids

CLC Number:

R563.1

Zang Jiajia, Gao Yanfeng, Han Shuzhi, Ping Fen. Acute eosinophilic pneumonia in the elderly: A case report and literature review[J]. Clinical Focus, 2022, 37(10): 931-933.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2022.10.009

https://huicui.hebmu.edu.cn/EN/Y2022/V37/I10/931

Figures/Tables 4

References 19

[1]	Allen J, Wert M. Eosinophilic pneumonias[J]. J Allergy Clin Immunol Pract, 2018, 6(5): 1455-1461. doi: S2213-2198(18)30269-1 pmid: 29735405
[2]	Chaaban T. Acute eosinophilic pneumonia associated with non-cigarette smoking products: A systematic review[J]. Adv Respir Med, 2020, 88(2): 142-146. doi: 10.5603/ARM.2020.0088 pmid: 32383466
[3]	Suzuki Y, Suda T. Eosinophilic pneumonia: A review of the previous literature, causes, diagnosis, and management[J]. Allergol Int, 2019, 68(4): 413-419. doi: S1323-8930(19)30067-X pmid: 31253537
[4]	Allen JN, Pacht ER, Gadek JE, et al. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure[J]. N Engl J Med, 1989, 321(9): 569-574. doi: 10.1056/NEJM198908313210903 URL
[5]	Zhang XD, Gong HH, Gao JM. Clinical analysis of 40 patients with eosinophilic lung diseases in Peking Union Medical College Hospital[J]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2018, 40(2): 170-177.
[6]	Kadyrova A, Antipina I, Kyrbasheva I, et al. CT patterns and differential criteria for acute eosinophilic pneumonia and COVID-19 pneumonia[J]. Clin Case Rep, 2021, 9(10): e04890.
[7]	Lozano Buj A, Bonnin Vilaplana M,, Jolis Olive R. Acute eosinophilic pneumonia with peripheric alveolar infiltrates[J]. Med Clin (Barc), 2019, 153(3): 126-127. doi: 10.1016/j.medcli.2018.05.035 URL
[8]	Ota K, Sasabuchi Y, Matsui H, et al. Age distribution and seasonality in acute eosinophilic pneumonia: Analysis using a national inpatient database[J]. BMC Pulm Med, 2019, 19(1): 38. doi: 10.1186/s12890-019-0800-3 pmid: 30755187
[9]	Fayyaz B. Acute eosinophilic pneumonia associated with smoking: A case report[J]. J Community Hosp Intern Med Perspect, 2018, 8(3): 119-122.
[10]	Zimmer MA, Haffner E, Weisser CW, et al. Daptomycin-induced eosinophilic pneumonia associated with an early endoprosthesis infection[J]. Anaesthesist, 2020, 69(6): 414-420. doi: 10.1007/s00101-020-00765-y pmid: 32270225
[11]	van Oortegem A, Meurice JC, Verdaguer M, et al. Case report of severe acute eosinophilic pneumonia induced by amoxicillin[J]. Rev Mal Respir, 2021, 38(5): 524-529. doi: 10.1016/j.rmr.2021.03.010 pmid: 33902969
[12]	de Giacomi F, Decker P A, Vassallo R, et al. Acute eosinophilic pneumonia: Correlation of clinical characteristics with underlying cause[J]. Chest, 2017, 152(2): 379-385. doi: S0012-3692(17)30360-4 pmid: 28286263
[13]	Araujo M, Correia S, Lima AL, et al. SARS-CoV-2 as a trigger of eosinophilic pneumonia[J]. Pulmonology, 2022, 28(1): 62-64. doi: 10.1016/j.pulmoe.2021.07.007 URL
[14]	de Giacomi F, Vassallo R, Yi ES, et al. Acute eosinophilic pneumonia. Causes, diagnosis, and management[J]. Am J Respir Crit Care Med, 2018, 197(6): 728-736. doi: 10.1164/rccm.201710-1967CI URL
[15]	Somoza-Cano FJ, Makadia A, Cruz-Peralta MP, et al. Acute eosinophilic pneumonia secondary to daptomycin[J]. Cureus, 2021, 13(11): e19403.
[16]	Yoshida K, Morishima Y, Ishii Y, et al. Clinical significance of invariant natural killer T cells and IL-5 in acute eosinophilic pneumonia[J]. Allergol Int, 2021, 70(2): 258-261. doi: 10.1016/j.alit.2020.09.013 pmid: 33191121
[17]	Akaba T, Kondo M, Hara K, et al. Tryptase and IL-33 in bronchoalveolar lavage fluid may predict the types of eosinophilic pneumonia and disease recurrence[J]. Int Arch Allergy Immunol, 2022, 183(4): 415-423. doi: 10.1159/000520180 URL
[18]	Bartal C, Sagy I, Barski L. Drug-induced eosinophilic pneumonia: A review of 196 case reports[J]. Medicine, 2018, 97(4): e9688. doi: 10.1097/MD.0000000000009688 URL
[19]	Cottin V. Eosinophilic lung diseases[J]. Clin Chest Med, 2016, 37(3): 535-556. doi: 10.1016/j.ccm.2016.04.015 pmid: 27514599